|
CUL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89197000000085E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.443100E-03 |
| Normal-vs-Stage2 |
1.761230E-01 |
| Normal-vs-Stage3 |
5.213800E-02 |
| Normal-vs-Stage4 |
3.650000E-02 |
| Stage1-vs-Stage2 |
9.411000E-01 |
| Stage1-vs-Stage3 |
8.007600E-01 |
| Stage1-vs-Stage4 |
6.578200E-01 |
| Stage2-vs-Stage3 |
8.016000E-01 |
| Stage2-vs-Stage4 |
6.328800E-01 |
| Stage3-vs-Stage4 |
7.822600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.981370E-04 |
| Normal-vs-AfricanAmerican |
1.073960E-02 |
| Normal-vs-Asian |
3.481600E-01 |
| Caucasian-vs-AfricanAmerican |
9.590000E-01 |
| Caucasian-vs-Asian |
6.792800E-01 |
| AfricanAmerican-vs-Asian |
6.587200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.163700E-04 |
| Normal-vs-Female |
1.508139999995E-05 |
| Male-vs-Female |
8.040500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.794200E-02 |
| Normal-vs-Extreme_Weight |
5.143800E-03 |
| Normal-vs-Obese |
2.044700E-03 |
| Normal-vs-Extreme_Obese |
9.628000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.161000E-01 |
| Normal_Weight-vs-Obese |
6.347600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.373800E-01 |
| Extreme_Weight-vs-Obese |
9.037000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.633200E-01 |
| Obese-vs-Extreme_Obese |
1.589960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.563100E-04 |
| Normal-vs-Age(41-60Yrs) |
8.05879999954406E-07 |
| Normal-vs-Age(61-80Yrs) |
5.679900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.775200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.407400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.181500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.442200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.043700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.656800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.934800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.72500000342291E-08 |
| Normal-VS-Type2 PRCC |
7.724400E-01 |
| Normal-VS-KIRP CIMP |
5.54409999999894E-05 |
| Normal-VS-Unclassified PRCC |
1.498590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.14399999999282E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.922000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.190830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.409900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.233040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.379040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.907400E-01 |
| Normal-vs-N1 |
2.082300E-03 |
| Normal-vs-N2 |
1.108190E-02 |
| N0-vs-N1 |
6.062700E-03 |
| N0-vs-N2 |
4.355100E-03 |
| N1-vs-N2 |
5.549800E-01 |
|
|
